About this episode

Maureen Testoni discusses Eli Lilly's demands for hospitals regarding 340B drug discounts.

Maureen Testoni, the stalwart president and CEO of the renowned 340B Health Program, will join the long-running Monitor Mondays to discuss Eli Lilly’s escalating demands for hospitals to submit in-house claims data as a condition of receiving 340B drug discounts. Who will blink first? Register now to reserve your participation. Broadcast segments will also include these instantly recognizable features: · Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, wil...

Topics covered

• 340B drug discounts
• hospital claims data
• healthcare controversy
• Eli Lilly
• 340B Health Program

More episodes of Monitor Mondays

• The Latest Compliance Trap: Medicare Cost Reports · July 20, 2026 · 31 min
• Preventing Denials: The Role of Facility-Based Clinical Definitions · July 13, 2026 · 31 min
• Behavioral Health: Avoiding Common Pitfalls · July 6, 2026 · 32 min
• Avoiding the Next Claim Denial · June 29, 2026 · 29 min
• Seeking Compliance Across the Revenue Cycle · June 22, 2026 · 27 min

Explore listener stats, chart rankings, contacts and more on the Monitor Mondays podcast page.